BaroFold Company

BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company's goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMTâ„¢ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.
Technology: P4 Medicine
Industry: Biopharma, Biotechnology, Therapeutics
Headquarters: Aurora, Colorado, United States
Founded Date: 2003-01-01
Employees Number: 1-10
Investors Number: 1
Total Funding: $3.2M
Estimated Revenue: $1M to $10M
Last Funding Type: Corporate Round

Visit Website
info@barofold.com
Register and Claim Ownership